McKesson Quarterly Cash Flow Statement
NYSE: MCKHealth CareOther PharmaceuticalsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
McKesson free cash flow
In the quarter ended Jun 30, 2026, McKesson generated -$220.0 million of operating cash flow and spent $112.0 million on capital expenditures. That left free cash flow of -$332.0 million, a free-cash-flow margin of -0.3% of revenue. McKesson returned $2.63 billion to shareholders: $102.0 million in dividends and $2.53 billion in share repurchases.
Summary generated from market data by MetaCap's automated system. Methodology
McKesson cash flow statement (quarterly)
| Quarter (USD) | Q1 20272026-06-30 | Q4 20262026-03-31 | Q3 20262025-12-31 | Q2 20262025-09-30 | Q1 20262025-06-30 | Q4 20252025-03-31 | Q3 20252024-12-31 | Q2 20252024-09-30 | Q1 20252024-06-30 | Q4 20242024-03-31 | Q3 20242023-12-31 | Q2 20242023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 1.03B | 1.85B | 1.25B | 1.16B | 831.00M | 1.31B | 928.00M | 287.00M | 960.00M | 830.00M | 630.00M | 703.00M |
| Net Income growth (YoY) | +24.19% | +42.04% | +34.70% | +305.23% | -13.44% | +57.35% | +47.30% | -59.17% | -3.71% | +0.48% | -43.75% | -27.30% |
| Depreciation & Amortization | 195.00M | 196.00M | 188.00M | 188.00M | 157.00M | 151.00M | 153.00M | 163.00M | 169.00M | 62.00M | 62.00M | 65.00M |
| Change in Working Capital | -675.00M | 2.57B | -1.01B | 1.79B | -2.11B | 6.62B | -3.93B | 1.34B | -1.93B | 2.86B | -1.27B | 484.00M |
| Operating Cash Flow | -220.00M | 3.42B | 1.23B | 2.42B | -918.00M | 7.75B | -2.38B | 2.10B | -1.38B | 4.15B | 254.00M | 965.00M |
| Capital Expenditures | -112.00M | -111.00M | -108.00M | -106.00M | -111.00M | -169.00M | -126.00M | -136.00M | -106.00M | -188.00M | -90.00M | -75.00M |
| Investing Cash Flow | -214.00M | 425.00M | -269.00M | -24.00M | -3.56B | -224.00M | -136.00M | -286.00M | -87.00M | -577.00M | -180.00M | -166.00M |
| Dividends Paid | -102.00M | -101.00M | -101.00M | -89.00M | -90.00M | -91.00M | -92.00M | -80.00M | -82.00M | -82.00M | -83.00M | -75.00M |
| Share Repurchases | -2.53B | -2.67B | -680.00M | -818.00M | -581.00M | -300.00M | -827.00M | -1.49B | -527.00M | -678.00M | -842.00M | -809.00M |
| Debt Issued | 3.21B | 0 | 0 | 0 | 1.99B | 0 | 0 | 498.00M | 0 | 0 | 0 | 0 |
| Debt Repaid | -1.00M | -8.00M | -1.20B | -2.00M | 0 | -9.00M | -9.00M | -501.00M | 0 | -8.00M | -9.00M | -3.00M |
| Financing Cash Flow | 1.63B | -2.82B | -2.03B | -961.00M | 1.18B | -2.85B | 1.30B | -1.60B | -809.00M | -968.00M | -622.00M | -909.00M |
| Net Change in Cash | 1.19B | 1.01B | -1.06B | 1.43B | -3.27B | 4.67B | -1.23B | 207.00M | -2.28B | 2.60B | -541.00M | -113.00M |
| Free Cash Flow | -332.00M | 3.31B | 1.12B | 2.31B | -1.03B | 7.58B | -2.51B | 1.96B | -1.49B | 3.96B | 164.00M | 890.00M |
This table shows 12 quarterly periods of McKesson's cash flow statement, from Q1 2027 back to Q2 2024, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow MCK's reporting calendar. What is a cash flow statement?